IT9019141A0 - Trattamento di malattie associate ad infezioni di hiv - Google Patents

Trattamento di malattie associate ad infezioni di hiv

Info

Publication number
IT9019141A0
IT9019141A0 IT19141A IT1914190A IT9019141A0 IT 9019141 A0 IT9019141 A0 IT 9019141A0 IT 19141 A IT19141 A IT 19141A IT 1914190 A IT1914190 A IT 1914190A IT 9019141 A0 IT9019141 A0 IT 9019141A0
Authority
IT
Italy
Prior art keywords
treatment
diseases associated
hiv infections
hiv
infections
Prior art date
Application number
IT19141A
Other languages
English (en)
Other versions
IT9019141A1 (it
IT1237999B (it
Inventor
Wulf Droge
Leonard A Herzenberg
Leonore A Herzenberg
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of IT9019141A0 publication Critical patent/IT9019141A0/it
Publication of IT9019141A1 publication Critical patent/IT9019141A1/it
Application granted granted Critical
Publication of IT1237999B publication Critical patent/IT1237999B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IT01914190A 1989-01-26 1990-01-24 Trattamento di malattie associate ad infezioni di hiv IT1237999B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30239689A 1989-01-26 1989-01-26

Publications (3)

Publication Number Publication Date
IT9019141A0 true IT9019141A0 (it) 1990-01-24
IT9019141A1 IT9019141A1 (it) 1991-07-24
IT1237999B IT1237999B (it) 1993-06-21

Family

ID=23167578

Family Applications (1)

Application Number Title Priority Date Filing Date
IT01914190A IT1237999B (it) 1989-01-26 1990-01-24 Trattamento di malattie associate ad infezioni di hiv

Country Status (25)

Country Link
US (1) US5607974A (it)
JP (1) JPH04504570A (it)
KR (1) KR940002820B1 (it)
AU (1) AU639686B2 (it)
BE (1) BE1004168A3 (it)
CA (3) CA1339070C (it)
CH (1) CH683499A5 (it)
DE (1) DE4090165T (it)
DK (1) DK139191A (it)
FR (1) FR2643557B1 (it)
GB (1) GB2243296B (it)
GR (1) GR900100048A (it)
IE (1) IE62795B1 (it)
IL (1) IL93162A (it)
IT (1) IT1237999B (it)
LU (1) LU87977A1 (it)
MA (1) MA21739A1 (it)
MX (1) MX173567B (it)
NL (1) NL9020094A (it)
OA (1) OA09503A (it)
PT (1) PT92949B (it)
SE (1) SE9101815D0 (it)
TN (1) TNSN90009A1 (it)
WO (1) WO1990008540A1 (it)
ZA (1) ZA90245B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9205549A (es) * 1991-09-30 1993-05-01 Jess G Thoene Metodo para el tratamiento de vih.
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
EP0600462A1 (en) * 1992-12-01 1994-06-08 Nippon Flour Mills Co., Ltd. Reverse transcriptase inhibitors and antiviral agents
AU6060694A (en) * 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome
DE4325547C2 (de) * 1993-07-29 1997-11-27 Max Planck Gesellschaft Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen
EP0789565A4 (en) * 1993-10-15 1999-03-24 Jess G Thoene PREVENTION OF HIV INFECTION
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
US5786152A (en) * 1996-04-26 1998-07-28 Amgen Inc. Methods of inhibiting syp binding to a CTLA-4 receptor
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
TW517089B (en) 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
JP4578578B2 (ja) * 1997-01-13 2010-11-10 エモリー、ユニバーシティ インフルエンザ感染の治療用化合物及びそれらの組み合わせ
US6331610B1 (en) * 1997-04-25 2001-12-18 Metatron, Inc. Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin
US6020205A (en) * 1998-04-10 2000-02-01 Immunosciences Lab, Inc. Determination of intracellular antioxidant levels
US6251868B1 (en) * 1998-04-30 2001-06-26 Teijin Limited Method for treating a human immunodeficiency virus infection
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
US6355682B1 (en) * 2001-05-11 2002-03-12 Assa Weinberg Treatment of acute renal failure by administration of N-acetylcysteine
ITMI20011863A1 (it) * 2001-09-05 2003-03-05 Zambon Spa Associazione di farmaci contro il virus dell'influenza
US20050070607A1 (en) * 2003-08-19 2005-03-31 James Andrus N-acetylcysteine compositions and methods for the treatment and prevention of cysteine/glutathione deficiency in diseases and conditions
JP5027512B2 (ja) 2003-11-14 2012-09-19 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫調節法
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
US20070053970A1 (en) * 2005-05-25 2007-03-08 Guilford F T Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148885A (en) * 1973-09-25 1979-04-10 Institut Merieux Immunostimulant medicine
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
US4434158A (en) * 1981-02-11 1984-02-28 Cornell Research Foundation Cysteine delivery system
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
US4647571A (en) * 1981-02-11 1987-03-03 Cornell Research Foundation Cysteine delivery composition
US4438124A (en) * 1981-02-11 1984-03-20 Cornell Research Foundation, Inc. Cysteine delivery system
US4879370A (en) * 1983-12-02 1989-11-07 Cornell Research Foundation, Inc. Glutathione delivery system
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US4710489A (en) * 1985-04-22 1987-12-01 Cornell Research Foundation, Inc. Glutathione delivery system
US4758551A (en) * 1986-07-08 1988-07-19 Cornell Research Foundation, Inc. Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types
DE3707127C2 (de) * 1987-03-05 1996-06-20 Zambon Spa Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
DE3812008A1 (de) * 1987-04-10 1988-10-20 Pfrimmer Pharma Verwendung von l-(-)-thiazolidin-4-carbonsaeure als cysteinquelle bei gestoerter cysteinsynthese
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
DE3906671A1 (de) * 1989-03-02 1990-09-06 Wulf Prof Dr Droege Orales, magenvertraegliches n-acetylcysteinpraeparat hoher dosierung

Also Published As

Publication number Publication date
OA09503A (en) 1992-11-15
PT92949A (pt) 1990-07-31
KR910700045A (ko) 1991-03-13
MX173567B (es) 1994-03-16
IL93162A0 (en) 1990-11-05
IE900073L (en) 1990-07-26
GB2243296B (en) 1992-10-21
GB2243296A (en) 1991-10-30
CA2045180A1 (en) 1990-07-27
CH683499A5 (it) 1994-03-31
CA1339070C (en) 1997-07-29
JPH04504570A (ja) 1992-08-13
WO1990008540A1 (en) 1990-08-09
GR900100048A (el) 1991-06-07
IE62795B1 (en) 1995-03-08
SE9101815L (sv) 1991-06-13
MA21739A1 (fr) 1990-10-01
FR2643557B1 (fr) 1995-02-03
AU4969490A (en) 1990-08-24
ZA90245B (en) 1990-10-31
NL9020094A (nl) 1991-10-01
AU639686B2 (en) 1993-08-05
PT92949B (pt) 1995-12-29
US5607974A (en) 1997-03-04
IT9019141A1 (it) 1991-07-24
LU87977A1 (fr) 1992-03-11
DK139191D0 (da) 1991-07-25
DK139191A (da) 1991-07-25
IL93162A (en) 1995-03-15
TNSN90009A1 (fr) 1991-03-05
BE1004168A3 (fr) 1992-10-06
CA1339256C (en) 1997-08-12
KR940002820B1 (ko) 1994-04-04
GB9112420D0 (en) 1991-07-31
SE9101815D0 (sv) 1991-06-13
DE4090165T (it) 1991-11-21
FR2643557A1 (fr) 1990-08-31
IT1237999B (it) 1993-06-21

Similar Documents

Publication Publication Date Title
IT1237999B (it) Trattamento di malattie associate ad infezioni di hiv
IT8847858A0 (it) Agenti per la profilassi e la terapia di infezioni retrovirali
PT87039A (pt) Treatment of human viral infections by dsrna combined with viral inhibitors
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
IT1229484B (it) Virus ricombinante delle malattie esantematiche dei vertebrati.
NO905428L (no) Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids.
LV5824B4 (lv) Cilveku psihozes arstesanas panemiens
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
PT88684A (pt) Metodo de tratamento fosfatidilico de doencas virais
NO940810D0 (no) Behandling av virusinfeksjoner
EP0522081A4 (en) Inhibition of disease associated with immunodeficiency virus infection
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
FR2694384B1 (fr) Traitement de la surface de réfractaires.
DE69004451T2 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
IT1224636B (it) Esteri penem 6 sostituiti come agenti antinfiammatori e antidegenerativi.
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
IT1239064B (it) Uso terapeutico del dipiridamolo
KR900015532U (ko) 일부인
NO960551D0 (no) Antistoff basert behandling av HIV infeksjon
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
IT9019699A0 (it) Procedimento di purificazione del b-interferone umano ricombinante
ES2019251A4 (es) Produccion de alfa-cloro-alfa-oximino-4-hidroxilo acetofenona.
IT8921426A0 (it) Processo per la preparazione di monobattami ed intermedio di preparazione.
DE3886526D1 (de) Mittel zur verhinderung der progredienz der erkrankung nach hiv-virusinfektionen.
IE892991L (en) Treatment of viral infections

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970129